|
Variable
|
Group A (N = 17)
|
Group B (N = 23)
|
P value
|
|---|
|
Number of hips
|
22
|
29
| |
|
Age, years
|
35.4 ± 11.1
|
39.4 ± 10.4
|
0.252
|
|
Sex
| | |
0.605
|
|
Male
|
12 (70.6%)
|
19 (82.6%)
|
|
Female
|
5 (29.4%)
|
4 (17.4%)
|
|
Weight (kg)
|
65.6 ± 14.7
|
65.3 ± 7.7
|
0.949
|
|
Hip involved unilateral
|
12 (70.6%)
|
17 (73.9%)
|
1.000
|
|
Hip involved bilateral
|
5 (29.4%)
|
6 (26.1%)
|
|
Etiology
| | |
0.080
|
|
Steroid
|
8 (36.4%)
|
3 (10.3%)
|
|
Alcohol
|
5 (22.7%)
|
9 (31.1%)
|
|
Idiopathic
|
9 (40.9%)
|
17 (58.6%)
|
|
Ficat stage
| | |
0.114
|
|
Stage I
|
1 (4.5%)
|
1 (3.4%)
|
|
Stage II
|
19 (86.4%)
|
20 (69.0%)
|
|
Stage III
|
2 (9.1%)
|
6 (20.7%)
|
|
Stage IV
|
0 (0)
|
2 (6.9%)
|
|
Pain scores
|
17.7 ± 4.3
|
17.6 ± 5.1
|
0.917
|
|
Function scores
|
49.5 ± 7.8
|
50.9 ± 9.0
|
0.550
|
|
Harris Hip Scores
|
67.2 ± 9.2
|
68.5 ± 13.1
|
0.678
|
- Group A, bone marrow buffy coat graft group; group B, control group
